Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles

Beijing Gene+ Raises $38 Million for Cancer Diagnostics
Ascentage to Start China Trials of Bcl-2 Apoptosis Candidate
Week in Review: BeiGene Plans $2.5 Billion IPO on Shanghai Star Exchange
Antengene Completes $340 Million Hong Kong IPO for Oncology Drugs
China COVID-19 Vaccines and Antibody Treatments Advancing toward Approvals
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

ChinaBio Partnering Forum 2020

Content Availbalble Until Dec. 21, 2020